search

The Commission is mobilising €123 million from Horizon Europe, the new EU research and innovation programme, for urgent research into coronavirus variants. This first emergency funding under Horizon Europe contributes to the Commission’s overall action to prevent, mitigate and respond to the impact of coronavirus variants, in line with the new European bio-defence preparedness plan HERA Incubator.

They will support the development of large scale, COVID-19 cohorts and networks beyond Europe’s borders, forging links with European initiatives, as well as reinforce the infrastructures needed to share data, expertise, research resources and expert services among researchers and research organisations.

The projects funded are expected to:

  • Establish new and/or build on existing large-scale, multi-centre and regional or multinational cohorts, including beyond Europe’s borders, which should rapidly advance the knowledge on SARS-CoV-2 and its emerging variants.
  • Further develop promising therapeutic or vaccine candidates against SARS-CoV-2/COVID-19, having already completed preclinical development in clinical studies.
  • Support research infrastructures to speed up data sharing and deliver fast research support and expertise, to confront the coronavirus variants and to be ready for future epidemics.

The successful consortia are expected to collaborate with other relevant initiatives and projects at national, regional, and international level to maximise synergies and complementarity and avoid duplication of the research efforts.

Calls

These emergency calls will tackle the short to medium-term threat and simultaneously prepare for the future. They will contribute to building the European Health Emergency Preparedness and Response Authority (HERA), which will enable the EU to anticipate and better tackle future pandemics.

The calls will open for submissions on 13 April and the deadline for submission is 6 May 2021. The new solutions need to be available and affordable for all, in line with the principles of the Coronavirus Global Response.

Read more

European Parliament adopts Horizon Europe programme

29-04-2021

The 2021-2027 research and innovation programme will help the EU’s health systems prepare for future pandemics, and its industry to decarbonise, digitalise and innovate.
Read more

Postdoctoral Marie Curie Fellowship opportunities in Luxembourg

16-04-2021

Luxinnovation supports Luxembourg organisations wishing to further develop their capacities by hosting researchers in the framework of the Marie Curie postdoctoral fellowship programme (MSCA PF). Any highly skilled researchers who have recently completed their postgraduate studies can apply until 15 May 2021.
Read more

Opening of the first Horizon Europe calls and publication of the first strategic documents

23-03-2021

Horizon Europe kicks off with the opening of the first calls and the announcement of the first deadlines.
Read more

Horizon Europe's first strategic plan 2021-2024

22-03-2021

The European Commission adopted the first strategic plan for Horizon Europe, the new EU research and innovation programme worth €95.5 billion in current prices. The strategic plan is a novelty in Horizon Europe and sets the strategic orientations for the targeting of investments in the programme's first four years.
Read more

EuroCC: Boosting the National Competence Centre in HPC

17-03-2021

Luxinnovation, together with the University of Luxembourg and LuxProvide, the company hosting the supercomputer MeluXina, is participating to the EuroCC project.
Read more

Resources all news

Close